ICL Israel Chemicals Ltd (ICL) - Net Assets

Latest as of September 2025: ILA6.38 Billion ILA ≈ $17.11 Million USD

Based on the latest financial reports, ICL Israel Chemicals Ltd (ICL) has net assets worth ILA6.38 Billion ILA (≈ $17.11 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA12.26 Billion ≈ $32.87 Million USD) and total liabilities (ILA5.88 Billion ≈ $15.77 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how large is ICL Israel Chemicals Ltd's balance sheet for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric Value
Current Net Assets ILA6.38 Billion
% of Total Assets 52.04%
Annual Growth Rate 7.84%
5-Year Change 46.45%
10-Year Change 87.8%
Growth Volatility 13.85

ICL Israel Chemicals Ltd - Net Assets Trend (2000–2024)

This chart illustrates how ICL Israel Chemicals Ltd's net assets have evolved over time, based on quarterly financial data. For live valuation and market cap data, see market cap of ICL Israel Chemicals Ltd.

Annual Net Assets for ICL Israel Chemicals Ltd (2000–2024)

The table below shows the annual net assets of ICL Israel Chemicals Ltd from 2000 to 2024. Explore ICL Israel Chemicals Ltd (ICL) cash flow conversion to assess how effectively this company generates cash.

Year Net Assets Change
2024-12-31 ILA5.99 Billion
≈ $16.05 Million
-0.83%
2023-12-31 ILA6.04 Billion
≈ $16.18 Million
+5.67%
2022-12-31 ILA5.71 Billion
≈ $15.32 Million
+20.63%
2021-12-31 ILA4.74 Billion
≈ $12.70 Million
+15.85%
2020-12-31 ILA4.09 Billion
≈ $10.96 Million
+0.66%
2019-12-31 ILA4.06 Billion
≈ $10.89 Million
+3.73%
2018-12-31 ILA3.92 Billion
≈ $10.50 Million
+33.62%
2017-12-31 ILA2.93 Billion
≈ $7.86 Million
+10.19%
2016-12-31 ILA2.66 Billion
≈ $7.13 Million
-16.59%
2015-12-31 ILA3.19 Billion
≈ $8.55 Million
+6.26%
2014-12-31 ILA3.00 Billion
≈ $8.04 Million
-18.44%
2013-12-31 ILA3.68 Billion
≈ $9.86 Million
+8.20%
2012-12-31 ILA3.40 Billion
≈ $9.12 Million
+9.50%
2011-12-31 ILA3.10 Billion
≈ $8.32 Million
+17.55%
2010-12-31 ILA2.64 Billion
≈ $7.08 Million
-5.50%
2009-12-31 ILA2.79 Billion
≈ $7.49 Million
+11.31%
2008-12-31 ILA2.51 Billion
≈ $6.73 Million
+34.91%
2007-12-31 ILA1.86 Billion
≈ $4.99 Million
+6.75%
2006-12-31 ILA1.74 Billion
≈ $4.67 Million
+16.19%
2005-12-31 ILA1.50 Billion
≈ $4.02 Million
+22.55%
2004-12-31 ILA1.22 Billion
≈ $3.28 Million
+28.10%
2003-12-31 ILA955.81 Million
≈ $2.56 Million
+9.29%
2002-12-31 ILA874.58 Million
≈ $2.34 Million
+6.23%
2001-12-31 ILA823.29 Million
≈ $2.21 Million
-15.93%
2000-12-31 ILA979.32 Million
≈ $2.63 Million
--

Equity Component Analysis

This analysis shows how different components contribute to ICL Israel Chemicals Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1224.4% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings ILA5.76 Billion 100.70%
Common Stock ILA549.00 Million 9.59%
Other Comprehensive Income ILA-567.00 Million -9.91%
Total Equity ILA5.72 Billion 100.00%

ICL Israel Chemicals Ltd Competitors by Market Cap

The table below lists competitors of ICL Israel Chemicals Ltd ranked by their market capitalization.

Company Market Cap
Blackstone Secured Lending Fund
NYSE:BXSL
$5.48 Billion
Beijing Yanjing Brewery Co Ltd
SHE:000729
$5.49 Billion
Landstar System Inc
NASDAQ:LSTR
$5.49 Billion
Arcosa Inc
NYSE:ACA
$5.50 Billion
Ningbo Shanshan Co Ltd
SHG:600884
$5.48 Billion
Clal Insurance Enterprises Holdings Ltd
TA:CLIS
$5.47 Billion
Turkcell Iletisim Hizmetleri AS ORD
IS:TCELL
$5.47 Billion
Shandong Intco Medical Products Co Ltd
SHE:300677
$5.47 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in ICL Israel Chemicals Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 5,768,000,000 to 5,724,000,000, a change of -44,000,000 (-0.8%).
  • Net income of 407,000,000 contributed positively to equity growth.
  • Dividend payments of 251,000,000 reduced retained earnings.
  • Other comprehensive income decreased equity by 229,000,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income ILA407.00 Million +7.11%
Dividends Paid ILA251.00 Million -4.39%
Other Comprehensive Income ILA-229.00 Million -4.0%
Other Changes ILA29.00 Million +0.51%
Total Change ILA- -0.76%

Book Value vs Market Value Analysis

This analysis compares ICL Israel Chemicals Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 357.02x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 2107.04x to 357.02x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2003-12-31 ILA0.75 ILA1584.00 x
2004-12-31 ILA0.95 ILA1584.00 x
2005-12-31 ILA1.17 ILA1584.00 x
2006-12-31 ILA1.35 ILA1584.00 x
2007-12-31 ILA1.40 ILA1584.00 x
2008-12-31 ILA1.90 ILA1584.00 x
2009-12-31 ILA2.19 ILA1584.00 x
2010-12-31 ILA2.06 ILA1584.00 x
2011-12-31 ILA2.42 ILA1584.00 x
2012-12-31 ILA2.66 ILA1584.00 x
2013-12-31 ILA2.88 ILA1584.00 x
2014-12-31 ILA2.34 ILA1584.00 x
2015-12-31 ILA2.38 ILA1584.00 x
2016-12-31 ILA2.02 ILA1584.00 x
2017-12-31 ILA2.24 ILA1584.00 x
2018-12-31 ILA2.95 ILA1584.00 x
2019-12-31 ILA3.06 ILA1584.00 x
2020-12-31 ILA3.07 ILA1584.00 x
2021-12-31 ILA3.52 ILA1584.00 x
2022-12-31 ILA4.24 ILA1584.00 x
2023-12-31 ILA4.47 ILA1584.00 x
2024-12-31 ILA4.44 ILA1584.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently ICL Israel Chemicals Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 7.11%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 5.95%
  • • Asset Turnover: 0.60x
  • • Equity Multiplier: 1.98x
  • Recent ROE (7.11%) is below the historical average (23.04%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2000 10.93% 5.46% 0.55x 3.65x ILA8.54 Million
2002 10.55% 4.66% 0.66x 3.42x ILA4.85 Million
2003 10.87% 4.54% 0.76x 3.15x ILA8.27 Million
2004 21.28% 9.23% 0.89x 2.60x ILA132.80 Million
2005 28.28% 14.14% 0.90x 2.23x ILA272.90 Million
2006 21.56% 11.48% 0.90x 2.09x ILA200.51 Million
2007 29.84% 13.06% 0.88x 2.58x ILA356.14 Million
2008 82.04% 29.03% 1.20x 2.35x ILA1.76 Billion
2009 27.78% 16.92% 0.77x 2.13x ILA493.04 Million
2010 39.11% 18.00% 0.89x 2.44x ILA762.73 Million
2011 49.14% 21.39% 0.97x 2.37x ILA1.20 Billion
2012 38.53% 19.49% 0.86x 2.30x ILA962.98 Million
2013 22.40% 13.05% 0.79x 2.18x ILA453.18 Million
2014 15.59% 7.59% 0.73x 2.81x ILA166.18 Million
2015 16.81% 9.42% 0.60x 3.00x ILA206.20 Million
2016 -4.74% -2.27% 0.63x 3.32x ILA-379.40 Million
2017 12.73% 6.72% 0.62x 3.05x ILA78.10 Million
2018 32.80% 22.32% 0.64x 2.31x ILA861.90 Million
2019 12.10% 9.01% 0.57x 2.34x ILA82.50 Million
2020 0.28% 0.22% 0.52x 2.46x ILA-382.00 Million
2021 17.30% 11.26% 0.63x 2.45x ILA330.30 Million
2022 39.51% 21.56% 0.85x 2.15x ILA1.61 Billion
2023 11.22% 8.59% 0.65x 2.02x ILA70.20 Million
2024 7.11% 5.95% 0.60x 1.98x ILA-165.40 Million

Industry Comparison

This section compares ICL Israel Chemicals Ltd's net assets metrics with peer companies in the Agricultural Inputs industry.

Industry Context

  • Industry: Agricultural Inputs
  • Average net assets among peers: $170,803,000
  • Average return on equity (ROE) among peers: 10.42%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
ICL Israel Chemicals Ltd (ICL) ILA6.38 Billion 10.93% 0.92x $5.48 Billion
Amir Marketing and Investments in Agriculture Ltd (AMRK) $170.80 Million 10.42% 1.94x $131.89 Million

About ICL Israel Chemicals Ltd

TA:ICL Israel Agricultural Inputs
Market Cap
$5.48 Billion
ILA2.04 Trillion ILA
Market Cap Rank
#3369 Global
#18 in Israel
Share Price
ILA1584.00
Change (1 day)
+0.13%
52-Week Range
ILA1481.00 - ILA2472.00
All Time High
ILA3485.63
About

ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; sells various grades of p… Read more